SLS Group Amends Syra Health Ownership Filing

Ticker: SYRA · Form: SC 13G/A · Filed: Jan 24, 2024 · CIK: 1922335

Syra Health Corp SC 13G/A Filing Summary
FieldDetail
CompanySyra Health Corp (SYRA)
Form TypeSC 13G/A
Filed DateJan 24, 2024
Risk Levelmedium
Pages3
Reading Time4 min
Sentimentneutral

Complexity: simple

Sentiment: neutral

Topics: insider-ownership, amendment, institutional-investor

TL;DR

**SLS Group just updated their stake in Syra Health, watch for potential market reaction.**

AI Summary

SLS Group LLC, a Utah-based entity, filed an amended Schedule 13G/A on January 24, 2024, regarding its ownership in Syra Health Corp.'s Class A Common Stock. This filing indicates a change in their beneficial ownership, although the specific number of shares is not provided in the excerpt. Investors should note that this amendment signals a shift in a significant holder's position, which could influence market perception or liquidity for Syra Health Corp. stock.

Why It Matters

This filing signals a change in a major investor's stake, which can impact investor confidence and potentially the stock's trading volume or price.

Risk Assessment

Risk Level: medium — Changes in significant ownership can introduce volatility or signal underlying shifts in investor sentiment, posing a medium risk.

Analyst Insight

Investors should monitor subsequent filings from SLS Group LLC or Syra Health Corp. for specific details on the change in ownership, as this filing only indicates an amendment without providing the new share count in the provided text.

Key Players & Entities

  • SLS Group LLC (company) — reporting person, beneficial owner of Syra Health Corp. stock
  • Syra Health Corp. (company) — the issuer of the Class A Common Stock
  • 07 Trade & Services (company) — subject company organization name
  • Utah (company) — place of organization for SLS Group LLC
  • January 24, 2024 (date) — date of event requiring the filing

FAQ

What is the purpose of this SC 13G/A filing?

This SC 13G/A filing is an amendment (Amendment No. 1) to a previous Schedule 13G filing, indicating a change in the beneficial ownership of Class A Common Stock of Syra Health Corp. by SLS Group LLC, as required by the Securities Exchange Act of 1934.

Who is the reporting person in this filing?

The reporting person in this filing is SLS Group LLC, with an I.R.S. Identification No. of 26-3685947 and organized in Utah.

What is the subject company of this filing?

The subject company, or issuer, is Syra Health Corp., which has a CUSIP Number of 87168W203 for its Class A Common Stock.

When was the event that required this filing?

The date of the event which required the filing of this statement was January 24, 2024.

Under which rule was this Schedule 13G/A filed?

This Schedule 13G/A was filed pursuant to Rule 13d-1(c) of the Securities Exchange Act of 1934, as indicated by the checked box on the cover page.

Filing Stats: 1,033 words · 4 min read · ~3 pages · Grade level 7.3 · Accepted 2024-01-24 16:05:21

Filing Documents

From the Filing

SC 13G/A 1 formsc13ga.htm UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Syra Health Corp. (Name of Issuer) Class A Common Stock (Title of Class of Securities) 87168W203 (CUSIP Number) (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) January 24, 2024 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 87168W203 13G/A Page 2 of 6 Pages 1. NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) SLS Group LLC 26-3685947 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) (b) 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Utah NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 427,084 6. SHARED VOTING POWER 0 7. SOLE DISPOSITIVE POWER 427,084 8. SHARED DISPOSITIVE POWER 0 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 427,084 10. CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (see instructions) 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 7.64% 12. TYPE OF REPORTING PERSON (see instructions) PN CUSIP No. 87168W203 13G/A Page 3 of 6 Pages Item 1. (a) Name of Issuer Syra Health Corp. (b) Address of Issuer’s Principal Executive Offices 1119 Keystone Way North Suite 201 Carmel, IN 46032 Item 2. (a) Name of Person Filing Joe Thomas (b) Address of the Principal Office or, if none, residence 4580 S Thousand Oaks Drive Salt Lake City, UT 84124 (c) Citizenship United (d) Title of Class of Securities Class A Common Stock (e) CUSIP Number 87168W203 CUSIP No. 87168W203 13G/A Page 4 of 6 Pages Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o). (b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c). (c) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c). (d) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); (f) An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); (g) A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G); (h) A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) Group, in accordance with §240.13d-1(b)(1)(ii)(J). Item 4. Ownership. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: 427,084 (b) Percent of class: 7.64% (c) Number of shares as to which the person has: (i) Sole power to vote or to direct the vote. 427,084 (ii) Shared power to vote or to direct the vote. 0 (iii) Sole power to dispose or to direct the disposition of. 427,084 (iv) Shared power to dispose or to direct the disposition of. 0 Instruction . For computations regarding securities which represent a right to acquire an underlying security see §240.13d-3(d)(1). CUSIP No. 87168W203 13G/A Page 5 of 6 Pages Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following . Instruction . Dissolution of a group requires a response to this item. Item 6. Ownership of More than Five Percent on Behalf of Another Person. N/A Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported

View Full Filing

View this SC 13G/A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.